| Date Filed | Type | Description |
| 08/01/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/01/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/12/2023 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| MOOS WALTER H (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| LYONS GARY A (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Kotzin Brian L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 06/12/2023 |
SC 13G/A
| FMR LLC reports a 0.1% stake in RIGEL PHARMACEUTICALS INC |
| 05/15/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 05/02/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/07/2023 |
8-K
| Quarterly results |
| 03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/22/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in RIGEL PHARMACEUTICALS INC. |
| 02/14/2023 |
SC 13G
| GOLDMAN SACHS GROUP INC reports a 5.4% stake in RIGEL PHARMACEUTICALS INC |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 9.8% stake in Rigel Pharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 5.1% stake in RIGEL PHARMACEUTICALS INC |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 7% stake in Rigel Pharmaceuticals Inc. |
| 02/07/2023 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 300,000 shares
@ $0
Sold 20,340 shares
@ $1.75, valued at
$35.6k
Granted 600,000 options to buy
@ $1.87, valued at
$1.1M
|
|
| 02/06/2023 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,388 shares
@ $1.6602, valued at
$8.9k
|
|
| 02/06/2023 |
4
| Schorno Dean L (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,389 shares
@ $1.6601, valued at
$8.9k
|
|
| 02/06/2023 |
4
| Dummer Wolfgang (EVP & CMO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,389 shares
@ $1.6601, valued at
$8.9k
|
|
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2023 |
4
| Dummer Wolfgang (EVP & CMO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $2.42, valued at
$121k
|
|
| 01/30/2023 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.42, valued at
$484k
|
|
| 01/30/2023 |
4
| Schorno Dean L (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 63,000 shares
@ $0
Granted 50,000 options to buy
@ $2.42, valued at
$121k
Granted 125,000 options to buy
@ $1.87, valued at
$233.8k
|
|
|